Slide 1: Annual General Meeting 17 October 2011
Annual General For personal use only Meeting 17 October 2011
Slide 2: Ansell Limited Annual General Meeting
For personal use only ANSELL LIMITED ANNUAL GENERAL MEETING Magnus Nicolin Chief Executive Officer & Managing Director 17 October 2011
Slide 3: Disclaimer
Disclaimer For personal use only The following presentation has been prepared by Ansell Limited for information purposes only. The presentation may contain forward looking statements or statements of opinion. No representation or warranty is made regarding the accuracy, completeness or reliability o
Slide 4: F'11 was a Year of Significant Change
F’11 was A Year of Significant Change … For personal use only Ansell has re-organised and reengineered: Introduced Global Business Units and changed operating structure to a Matrix, to drive faster growth Integrated Sales & Operations Planning, Manufacturing, Sourcing, QA and Distribution. Improved
Slide 5: …and yet we continued to make large investments
…and yet we continued to make large investments For personal use only Fusion: ($21M) • North America went live July 2011, Brazil underway • Total Project Cost estimate increased to ~$80M Capability enhancement and Product Development ($15M) • Plant expansion/automation (Bangalore, Melaka, Bangkok, C
Slide 6: Despite the large cost hits and investments, F'11 was an Outstanding Year
Despite the large cost hits and investments, For personal use only F’11 was an Outstanding Year 6
Slide 7: Sustained focus on Shareholder Returns
Sustained focus on Shareholder Returns For personal use only -7% 35% 32% -11% 39% 45% TSR CAGR since inception of Ansell Ltd in April 2002 AUD ~11% USD ~19% F’03* F’04* F’05* F’06* F’07 F’08 F’09 F’10 F’11 CAGR AUD EPS 32.8 39.1 54.5 76.9 67.6 73.9 89.2 89.6 92.4 ~14% DPS 11.0 13.0 17.0 21.0 24.0 26
Slide 8: Portfolio Performance
Portfolio Performance For personal use only SALES $1206.9 EBIT $136.9m 11% 8% F '11 v F’10 F '11 v F’10 Industrial NV Medical SW Industrial NV Medical SW NA LAC EMEA AP Total > +5% From 0% to +5% < 0% Industrial: Outstanding global performance with all regions recording strong sales & EBIT growth NV
Slide 9: Industrial GBU Overview
Industrial GBU Overview For personal use only 39% of Revenue and 56% of Segment EBIT $M F’10 F’11 HyFlex® 144.0 178.1 24% Volume up 27% Other General Purpose 101.6 117.7 16% Chemical/Liquid Handling 59.5 70.9 19% AlphaTec® sales up 75% YoY Single Use *77.4 88.6 14% All Other 14.5 16.3 12% Sales *397
Slide 10: New Verticals GBU Overview
New Verticals GBU Overview For personal use only 14% of Revenue and 2% of Segment EBIT $M F’10 F’11 HHG - Retail 25.9 28.8 11% Flat Volumes, Chemical/Liquid Handling 43.0 49.1 14% better pricing Single Use *45.4 44.2 3% Government/First Responders 25.4 23.7 7% Better sales mix Other General Purpose
Slide 11: Medical GBU Overview
Medical GBU Overview For personal use only 30% of Revenue and 27% of Segment EBIT $M F’10 F’11 Surgical: PF 110.5 121.7 10% EMEA, AP each up 10% Powdered 59.6 65.1 9% APAC up 18%, EMEA 8% Synthetic 32.7 38.2 17% NA, APAC each up 20% Exams: NRL 75.7 69.7 8% Volumes down 25%, higher pricing Synthetic
Slide 12: Sandel Acquisition
Sandel Acquisition For personal use only “A recognised leader in the development of staff and patient safety products in the US” The Business: Acquired 1 July 2011 SAFETY DRIVEN PRODUCT LINE Sales approximately $10m p.a. Staff Safety Patient Safety Lean organisation with excellent innovation Sharps
Slide 13: Sexual Wellness GBU Overview
Sexual Wellness GBU Overview For personal use only 17% of Revenue and 15% of Segment EBIT $M F’10 F’11 Condoms: Branded 137.4 154.8 13% Growth in SKYN® and Emerging markets Tenders/Private Label 16.1 26.6 65% Brazil and India Tenders Launch of a:muse® (Australia) Lube/Devices/Other 16.8 19.2 14% Gro
Slide 14: Strong cash position provides options
Strong cash position provides options … For personal use only 160 Total Dividends $222m Investment in the business has Total Buybacks $461m 140 been increased with: 120 Sales force and geographical footprint expansion 100 Stepped up capex investment 80 in F’10 and F’11 Dividend increases have contin
Slide 15: F'11 in Perspective
F’11 in Perspective For personal use only Positives Negatives Excellent Organic Sales Growth Natural Rubber Latex (NRL) and other cost Industrial GBU acceleration increases, adversely impacted New Vertical & Medical GBU margins in particular Sexual Wellness GBU acceleration Fusion ERP go-live in Nor
Slide 16: F'12 Business Outlook
F’12 Business Outlook For personal use only • Cost pressures are reducing overall, with Natural Rubber latex (NRL) input prices running lower than expected but Nitrile (NBR) higher • Good momentum on exiting F’11 with Industrial, Sexual Wellness GBUs leading the way. Medical and New Verticals GBUs e
Slide 17: Guidance
Guidance For personal use only While the company faces a more uncertain global economy than envisaged in August, Ansell’s businesses overall continue to perform as expected. We re-affirm our F’12 EPS guidance to be within the previously communicated US97¢ - US103¢ range, up 6% - 12% from F’11’s US91